Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains

Biochemical Journal

Volumn 353, Issue 3, 2001, Pages 547-553

  Annabi, B ^a   Lachambre, M ^a   Bousquet Gagnon, N P ^a   Page M ^a   Gingras, D ^a   Beliveau R ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Angiogenesis; Cancer; Caveolin; Cell migration; Glioblastoma

Indexed keywords

CAVEOLIN 1; CONCANAVALIN A; CYTOCHALASIN D; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; TRITON X 100;

ANIMAL CELL; ARTICLE; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; TUMOR CELL LINE;

ANIMALS; BASE SEQUENCE; CELL MEMBRANE; CLONING, MOLECULAR; COS CELLS; DNA PRIMERS; DNA, COMPLEMENTARY; HYDROLYSIS; MATRIX METALLOPROTEINASE 1; OCTOXYNOL; RECOMBINANT PROTEINS;

ANIMALIA;

EID: 0035252979     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3530547     Document Type: Article

References (28)

1. Physiological roles of matrix metalloproteinases: Implications for tumor growth and metastasis
2. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion
3. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter
4. Regulation of cell invasion and morphogenesis in a three-dimensionat type 1 collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3
5. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover
6. Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain
7. Specialized surface protrusions of invasive cells, invadopodia and lamellipodia, have differential MT1-MMP, MMP-2, and TIMP-2 localization
8. Mechanisms for pro matrix metalloproteinase activation
9. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
10. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP)
11. The TIMP2 membrane type 1 metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A. A kinetic study
12. Caveolins, a family of scaffolding proteins for organizing 'preassembled signaling complexes' at the plasma membrane
13. Molecular genetics of the caveolin gene family: Implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy
14. Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3)
15. Localization of RhoA GTPase to endothelial caveolae-enriched membrane domains
16. Matrix metalloproteinases and their inhibitors in human pituitary tumors
17. Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase A activator (MT-MMP)
18. Matrix metalloproteinase inhibition by green tea catechins
19. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins
20. Matrix metalloproteinases: Structures, evolution, and diversification
21. The C-terminal (haemopexin-like) domain structure of human gelatinase A (MMP2): Structural implications for its function
22. Separation of caveolae from associated microdomains of GPI-anchored proteins
23. Rapid activation of matrix metalloproteinase-2 by glioma cells occurs through a posttranslational MT1-MMP-dependent mechanism
24. Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1
25. Relating matrix metalloproteinase structure to function: Why the 'hemopexin' domain?
26. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP
27. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion
28. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling